Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR) we wish to inform you that the Board of Directors (the Board) of ADS Diagnostic Limited (the Company) at its meeting held today i.e. Friday May 29th 2026 considered and approved the Audited Standalone Financial Results of the Company for the quarter/Year ended March 31st 2026.The board has recommend a dividend @ 12% per share i.e Rs. 1.20 per Share/(Rupees one and twenty paisa only) per equity share of face value of Rs. 10/- each fully paid up of the financial year 2025-26 subject approval of shareholders of the company.The Board Meeting commenced at 11:45 a.m. and concluded at 13:32 p.m
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
